Gero

Private

SingaporeHealthcare & Life Scienceshttps://www.gero.ai/

Last Round

Series A

Jun 17, 2026

Total Funding Raised

$34M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Gero is a biotechnology company that utilizes a physics-informed artificial intelligence platform to analyze real-world human health data for the discovery of novel therapeutics targeting aging and chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

drug discoveryAI drug discoverybiotech AIlongevity researchtherapeutic target identificationlarge health modelsin silico drug discoveryage-related diseasesgenerative biologymulti-omics datapreclinical researchtarget discoverybiotech platformdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gero Comps

Public and private peers based on sector, stage, and business model.

Gero comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gero Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 17, 2026
Series A Extension	Oct 18, 2023
Series A	Aug 4, 2020
Seed	May 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Peter Fedichev

Co-founder CEO

Founding Team

Alexey Lyapin

Chief Financial Officer

Executive Team

Aleksandr Sviridov

Chief Operating Officer

Executive Team

Gero Investors

Notable investors and investment history

Gero investors
Investor	Rounds
TOP Venture	Series A
VitaDAO	Series A Extension
Melnichek Investments	Series A, Series A Extension
Bulba Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 17, 2026
$17M raised with participation from Leonid Lozner and Melnichek Investments.
Jul 14, 2025
Brian Kennedy appointed to the Board of Directors.

View all signals

Gero Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Gero Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gero's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range137

Year Founded2018

Last FundingJun 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.